Therapeutic Uses
Anti-Hypertensives
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
Bisoprolol EP Impurity D, 1225195-71-0
Application Notes
Useful research chemical for a range of applications
Hazard Compound
No -Refer MSDS for accurate information
Bisoprolol EP Impurity D is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Bisoprolol EP Impurity D usage and description
Bisoprolol is a beta-blocker medication used primarily for the treatment of high blood pressure and heart failure. Bisoprolol EP Impurity D is a chemical compound that is related to bisoprolol and is considered an impurity in the manufacturing process of bisoprolol.
Bisoprolol EP Impurity D is a white to off-white crystalline powder that is insoluble in water but soluble in organic solvents such as methanol and acetonitrile. It is typically present in very small quantities in commercial batches of bisoprolol, usually less than 0.05% by weight.
While the presence of Bisoprolol EP Impurity D is not desirable in commercial batches of bisoprolol, it is not considered to be harmful to patients who take the medication. The impurity is not pharmacologically active and has not been found to cause any adverse effects on the body.
Manufacturers of bisoprolol are required to monitor and control the levels of Bisoprolol EP Impurity D in their products to ensure that they meet regulatory standards. This involves using analytical techniques such as high-performance liquid chromatography (HPLC) to measure the impurity levels and adjust the manufacturing process as needed to minimize its presence.
In conclusion, Bisoprolol EP Impurity D is a minor impurity in the manufacturing process of bisoprolol that does not pose a threat to patient safety. Its levels are monitored and controlled by manufacturers to ensure regulatory compliance.
